145 related articles for article (PubMed ID: 35136989)
1. LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer.
Gao Z; Long Y; Wu Y; Pu Y; Xue F
Carcinogenesis; 2022 Jun; 43(5):419-429. PubMed ID: 35136989
[TBL] [Abstract][Full Text] [Related]
2. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
3. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells.
Yan J; Huang X; Zhang X; Chen Z; Ye C; Xiang W; Huang Z
Biochem Biophys Res Commun; 2020 Jan; 521(4):887-893. PubMed ID: 31711642
[TBL] [Abstract][Full Text] [Related]
6. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X
FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949
[TBL] [Abstract][Full Text] [Related]
7. METTL3-Mediated lncRNA m
Song Y; Pan Y; Wu M; Sun W; Luo L; Zhao Z; Liu J
Stem Cell Rev Rep; 2021 Dec; 17(6):2276-2290. PubMed ID: 34505967
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
Hu N; Ji H
Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
[TBL] [Abstract][Full Text] [Related]
9. HBXIP promotes gastric cancer
Yang Z; Jiang X; Li D; Jiang X
Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
[TBL] [Abstract][Full Text] [Related]
10. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
[TBL] [Abstract][Full Text] [Related]
11. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
[TBL] [Abstract][Full Text] [Related]
12. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
[TBL] [Abstract][Full Text] [Related]
13. Dynamic N6-methyladenosine modification of lncRNA modulated by METTL3 during bacterial disease development in an echinoderm.
Zhang S; Shao Y; Li D; Li C
Fish Shellfish Immunol; 2022 May; 124():497-504. PubMed ID: 35483599
[TBL] [Abstract][Full Text] [Related]
14. m
Yang D; Chang S; Li F; Ma M; Yang J; Lv X; Huangfu L; Jia C
IUBMB Life; 2021 Nov; 73(11):1325-1333. PubMed ID: 34409730
[TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19.
Su Y; Xu R; Zhang R; Qu Y; Zuo W; Ji Z; Geng H; Pan M; Ma G
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1306-1315. PubMed ID: 33197240
[TBL] [Abstract][Full Text] [Related]
16. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.
Hou P; Meng S; Li M; Lin T; Chu S; Li Z; Zheng J; Gu Y; Bai J
J Exp Clin Cancer Res; 2021 Feb; 40(1):52. PubMed ID: 33526059
[TBL] [Abstract][Full Text] [Related]
17. METTL3-mediated m
Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
[TBL] [Abstract][Full Text] [Related]
18. A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR.
Liu H; Xu Y; Yao B; Sui T; Lai L; Li Z
Cell Death Dis; 2020 Aug; 11(8):613. PubMed ID: 32792482
[TBL] [Abstract][Full Text] [Related]
19. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
20. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
